Wat is de prijs voor PCL, Inc. (241820)

Het prijs van PCL, Inc. (241820) is $0.21291741

Wat is de marktkapitalisatie voor PCL, Inc. (241820)

Marktkapitalisatie voorPCL, Inc. (241820) is $12.07M

PCL, Inc. (241820) Prijs en Marktkapitalisatie

PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic (IVD) solutions, encompassing both diagnostic products and specialized platform services. The company's primary offerings include comprehensive multiplex kits designed to detect antibodies to Human Immunodeficiency Virus (HIV) types 1 and 2, Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human T-lymphotropic Virus (HTLV) types 1 and 2. These kits also identify specific antigens such as HIV p24, HCV core, and HBV surface markers in human serum or plasma samples. In addition to these, PCL markets Ai, a rapid diagnostic test kit capable of typing influenza A and B strains; Cancer6, a screening kit for multiple tumor biomarkers; and the sciLINER LATERAL FLOW DISPENSER, an advanced dispensing device for membrane materials featuring active visual drop volume control. Beyond its product portfolio, PCL offers valuable platform services. These include a sol-gel spotting service, which immobilizes client-specified materials using the proprietary SolB reagent, and an SG ID service, providing customers with identified molecules of interest securely immobilized within the SolB reagent. PCL, Inc. is headquartered in Seoul, South Korea.

Prijs voor 241820	Aandeel B	Marktkapitalisatie van B	uitslagen
$96,338.45 $12.07M	NVDA	$5.460T	+45,246,766.19%
$79,212.25 $12.07M	AAPL	$4.489T	+37,203,175.41%
$73,061.69 $12.07M	GOOG	$4.141T	+34,314,470.41%
$62,963.04 $12.07M	MSFT	$3.569T	+29,571,481.47%
$49,368.30 $12.07M	AMZN	$2.798T	+23,186,495.93%

Prijs voor 241820

Aandeel B

Marktkapitalisatie van B

uitslagen

$96,338.45 $12.07M